Facilitated By

San Antonio Medical Foundation

A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE SAFETY AND EFFICACY OF LX4211 IN COMBINATION WITH METFORMIN IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS WHO HAVE INADEQUATE GLYCEMIC CONTROL ON

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
DeFronzo,Ralph A
Funded by
LEXICON PHARMACEUTICALS
Research Start Date
Status
Inactive
Clinical Care
Drug Discovery
Diabetes and Obesity